Literature DB >> 2979207

[Cytokinetic effects of carboplatin and cisplatin on a human ovarian cancer cell line].

N Yoshizumi1, J Fujiwara, A Yoshizaki, M Sato, R Sakai, I Nishiya.   

Abstract

The cytokinetic effects of carboplatin(CBDCA) on a human ovarian cancer cell line(KF-1) were examined by means of cell survival rate and flow cytometry in comparison with cisplatin(CDDP). CBDCA and CDDP exhibited dose dependent cytotoxicity on KF-1, and CBDCA showed compatible cell growth inhibition to that of 15 times concentration of CDDP in comparison with IC50 of 72 hrs after drug addition. From the analysis of cell cycle, CBDCA and CDDP inhibited cell cycle progression at G2 + M phase. CBDCA exhibited G2 + M phase block to that of 15 to 20 times the concentration of CDDP. We suggested that CBDCA had potential therapeutic activity against ovarian cancer, but should be evaluated carefully in the clinical use.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2979207

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  3 in total

1.  Myricetin and methyl eugenol combination enhances the anticancer activity, cell cycle arrest and apoptosis induction of cis-platin against HeLa cervical cancer cell lines.

Authors:  Jin-Ling Yi; Song Shi; Yan-Li Shen; Ling Wang; Hai-Yan Chen; Jun Zhu; Yan Ding
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

2.  Combined anticancer activity of osthole and cisplatin in NCI-H460 lung cancer cells in vitro.

Authors:  Xiao-Man Xu; Yi Zhang; Dan Qu; Hong-Bo Liu; Xiu Gu; Guang-Yu Jiao; Li Zhao
Journal:  Exp Ther Med       Date:  2013-01-08       Impact factor: 2.447

3.  Ovarian and breast cancer spheres are similar in transcriptomic features and sensitive to fenretinide.

Authors:  Haiwei Wang; Yuxing Zhang; Yanzhi Du
Journal:  Biomed Res Int       Date:  2013-10-08       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.